Mallinckrodt - Top 10 Generic Drug Companies 2010

MallinckrodtCompany name: Mallinckrodt
Location: Hazelwood, MO
Annual sales (in millions): $860
Market share: 2.7%
President: Charles Bramlage

Brothers Edward, Otto, and Gustav Mallinckrodt began manufacturing fine chemicals for pharmaceutical products in 1867. The company has changed since then; in 2000, it was acquired by Tyco International. Then, in early 2006, Tyco announced it was dividing the conglomerate into three separate publicly traded companies in 2007, with Mallinckrodt operating within a stand-alone healthcare company to be named Covidien.

During its most recent quarter, Covidien as a whole reported an adjusted profit that beat estimates on better margins, but saw weak pharmaceutical sales, as Reuters notes. The pharma business saw sales of $507 million, down 6 percent from last year's third-quarter sales of $539 million. And generic products posted sharply decreased sales versus last year, primarily due to increased competitive activity, which is driving lower pricing, coupled with distributor inventory contraction, according to a company statement. Executives told analysts on a conference call that they expected 2010 pharmaceutical sales to be "well below" 2009 levels, as many of Covidien's older brands are facing expanded competition, Reuters reports.

Mallinckrodt - Top 10 Generic Drug Companies 2010
Read more on

Suggested Articles

While Lilly's 2018 launch Emgality is approved to prevent migraines, Reyvow is intended to treat them as they occur.

ICER's new draft review of RA drugs takes a different approach, reflecting how physicians treat the disease and the time horizon that's considered.

Johnson & Johnson is facing multibillion-dollar liabilities in thousands of talc and opioid cases. But that's not such a bad thing, one analyst said.